FDA approves Ozempic to reduce risk of kidney disease progression, cardiovascular death
The Food and Drug Administration approved Ozempic to be used to lessen the risk of kidney disease from getting worse, end-stage kidney disease and cardiovascular disease-caused death for patients with type 2 diabetes and chronic kidney disease.
No previous study has investigated whether glucarpidase improves important clinical outcomes in patients with methotrexate-associated acute kidney injury (AKI).
There’s hope for patients living with end-stage kidney disease complications in the Ashanti Region and beyond, as a team of specialists and surgeons succeed in a historic journey of performing a ...
People with kidney disease may be at higher risk of ... about your health or future Those with more advanced CKD or end stage renal disease (ESRD) may find that the demands of their ...
A group of doctors in Kumasi, Ashanti Region has performed a successful kidney transplant on a man who was diagnosed with end ...
A Northern Ireland mum with end stage kidney failure says she wants to be around to see her daughter grow up. Amy Mackay, 22 and from Carrickfergus, says her life has changed a lot in a short ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback